Oculopharyngeal muscular dystrophy as a paradigm for muscle aging

Frontiers in Aging Neuroscience

Volumn 6, Issue OCT, 2014, Pages

  Raz, Yotam ^a   Raz, Vered ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adult myopathy; Muscle degeneration; OPMD; PABPN1; RNA metabolism

Indexed keywords

RNA BINDING PROTEIN;

AGING; ARTICLE; DOWN REGULATION; DYSPHAGIA; EYELID MUSCLE; HUMAN; MOLECULAR PATHOLOGY; MUSCLE AGING; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PATHOPHYSIOLOGY; PHARYNGEAL MUSCLE; PHYSICAL PERFORMANCE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PTOSIS; RNA METABOLISM; SKELETAL MUSCLE;

EID: 84909642409     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00317     Document Type: Article

References (55)

1. Abu-Baker, A., Laganiere, S., Fan, X., Laganiere, J., Brais, B., and Rouleau, GA. (2005). Cytoplasmic Targeting of Mutant Poly (A)-Binding Protein Nuclear 1 Suppresses Protein Aggregation and Toxicity in Oculopharyngeal Muscular Dystrophy. Traffic 6, 766-779. doi: 10.1111/j.1600-0854.2005.00315.x.
2. Anthony, K., and Gallo, J.-M. (2010). Aberrant RNA processing events in neurological disorders. Brain Research 1338, 67-77. doi: http://dx.doi.org/10.1016/j.brainres.2010.03.008.
3. Anvar, S.Y., Raz, Y., Verway, N., Van Der Sluijs, B., Venema, A., Goeman, J.J., Vissing, J., Van Der Maarel, S.M., T Hoen, PA., Van Engelen, B.G., and Raz, V. (2013). A decline in PABPN1 induces progressive muscle weakness in Oculopharyngeal muscle dystrophy and in muscle aging. Aging (Albany NY) 5, 412-426.
4. Anvar, S.Y., T Hoen, PA., Venema, A., Van Der Sluijs, B., Van Engelen, B., Snoeck, M., Vissing, J., Trollet, C., Dickson, G., Chartier, A., Simonelig, M., Van Ommen, G.J., Van Der Maarel, S.M., and Raz, V. (2011). Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients. Skeletal muscle 1,15. doi: 10.1186/2044-5040-1-15.
5. Apponi, L.H., Corbett, A.H., and Pavlath, G.K. (2013). Control of mRNA stability contributes to low levels of nuclear poly (A) binding protein 1 (PABPN1) in skeletal muscle. Skelet Muscle 3, 2044-5040.
6. Apponi, L.H., Leung, S.W., Williams, K.R., Valentini, S.R., Corbett, A.H., and Pavlath, G.K. (2010). Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis. Human molecular genetics 19,1058-1065. doi: 10.1093/hmg/ddp569.
7. Beaulieu, Y.B., Kleinman, C.L., Landry-Voyer, A.M., Majewski, J., and Bachand, F. (2012). Polyadenylation-dependent control of long noncoding RNA expression by the poly (A)-binding protein nuclear 1. PLoS Genet 8, e1003078. doi: 10.1371/journal.pgen.1003078.
8. Benoit, B., Mitou, G., Chartier, A., Temme, C., Zaessinger, S., Wahle, E., Busseau, I., and Simonelig, M. (2005). An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila. Dev Cell 9, 511-522. doi: 10.1016/j.devcel.2005.09.002.
9. Berciano, M.T., Villagra, N.T., Ojeda, J.L., Navascues, J., Gomes, A., Lafarga, M., and Carmo-Fonseca, M. (2004). Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus. Human molecular genetics 13, 829-838. doi: 10.1093/hmg/ddh101.
10. Bhattacharjee, R.B., and Bag, J. (2012). Depletion of Nuclear Poly(A) Binding Protein PABPN1 Produces a Compensatory Response by Cytoplasmic PABP4 and PABP5 in Cultured Human Cells. PLoS ONE 7, e53036. doi: 10.1371/journal.pone.0053036.
11. Blumen, S.C., Korczyn, A.D., Lavoie, H., Medynski, S., Chapman, J., Asherov, A., Nisipeanu, P., Inzelberg, R., Carasso, R.L., Bouchard, J.P., Tome, F.M., Rouleau, G.A., and Brais, B. (2000). Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology 55,1267-1270.
12. Bonaldo, P., and Sandri, M. (2013). Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 6, 25-39. doi: 10.1242/dmm.010389.
13. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohira, O., Blumen, S., Korczyn, A.D., Heutink, P., Mathieu, J., Duranceau, A., Codere, F., Fardeau, M., and Rouleau, G.A. (1998). Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nature genetics 18,164-167. doi: 10.1038/ng0298-164.
14. Bresson, S.M., and Conrad, N.K. (2013). The human nuclear poly(a)-binding protein promotes RNA hyperadenylation and decay. PLoS Genet 9, e1003893. doi: 10.1371/journal.pgen.1003893.
15. Calado, A., Tome, F.M., Brais, B., Rouleau, G.A., Kuhn, U., Wahle, E., and Carmo- Fonseca, M. (2000). Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Human molecular genetics 9, 2321-2328.
16. Catoire, H., Pasco, M.Y., Abu-Baker, A., Holbert, S., Tourette, C., Brais, B., Rouleau, G.A., Parker, J.A., and Neri, C. (2008). Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. Human molecular genetics 17, 2108-2117. doi: ddn109 [pii] 10.1093/hmg/ddn109.
17. Chartier, A., Raz, V., Sterrenburg, E., Verrips, C.T., Van Der Maarel, S.M., and Simonelig, M. (2009). Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo. Human molecular genetics 18,1849-1859. doi: ddp101 [pii] 10.1093/hmg/ddp101.
18. Corbeil-Girard, L.P., Klein, A.F., Sasseville, A.M., Lavoie, H., Dicaire, M.J., Saint- Denis, A., Page, M., Duranceau, A., Codere, F., Bouchard, J.P., Karpati, G., Rouleau, G.A., Massie, B., Langelier, Y., and Brais, B. (2005). PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions. Neurobiology of disease 18, 551-567. doi: S0969-9961(04)00245-1 [pii] 10.1016/j.nbd.2004.10.019.
19. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., Martin, F.C., Michel, J.P., Rolland, Y., Schneider, S.M., Topinkova, E., Vandewoude, M., Zamboni, M., and European Working Group on Sarcopenia in Older, P. (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412-423. doi: 10.1093/ageing/afq034.
20. Davies, J.E., Rose, C., Sarkar, S., and Rubinsztein, D.C. (2010). Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy. Sci Transl Med 2, 34ra40. doi: 2/34/34ra40 [pii] 10.1126/scitranslmed.3000723.
21. Davies, J.E., Sarkar, S., and Rubinsztein, D.C. (2006). Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Human molecular genetics 15, 23-31.doi:ddi422 [pii] 10.1093/hmg/ddi422.
22. Davies, J.E., Sarkar, S., and Rubinsztein, D.C. (2008). Wild-type PABPN1 is antiapoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. Human molecular genetics 17,1097-1108. doi: ddm382 [pii] 10.1093/hmg/ddm382.
23. Davies, J.E., Wang, L., Garcia-Oroz, L., Cook, L.J., Vacher, C., Odonovan, D.G., and Rubinsztein, D.C. (2005). Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nature medicine 11, 672-677. doi: nm1242 [pii] 10.1038/nm1242.
24. De Klerk, E., Venema, A., Anvar, S.Y., Goeman, J.J., Hu, O., Trollet, C., Dickson, G., Den Dunnen, J.T., Van Der Maarel, S.M., Raz, V., and T Hoen, P.A. (2012). Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res 40, 9089-9101. doi: 10.1093/nar/gks655.
25. Eshed, I., Bollow, M., Mcgonagle, D.G., Tan, A.L., Althoff, C.E., Asbach, P., and Hermann, K.G. (2007). MRI of enthesitis of the appendicular skeleton in spondylarthritis. Ann Rheum Dis 66,1553-1559. doi: 10.1136/ard.2007.070243.
26. Fea, A., Damato, D., Actis, A.G., De Sanctis, U., Actis, G., and Grignolo, F.M. (2013). Blepharoplastic: essential review. Minerva Chir68, 49-56.
27. Feng, X., Todd, T., Lintzenich, C.R., Ding, J., Carr, J.J., Ge, Y., Browne, J.D., Kritchevsky, S.B., and Butler, S.G. (2013). Aging-related geniohyoid muscle atrophy is related to aspiration status in healthy older adults. J Gerontol A Biol Sci Med Sci 68, 853-860. doi: 10.1093/gerona/gls225.
28. Fischmann, A., Hafner, P., Fasler, S., Gloor, M., Bieri, O., Studler, U., and Fischer, D. (2012). Quantitative MRI can detect subclinical disease progression in muscular dystrophy. Journal of neurology. doi: 10.1007/s00415-011-6393-2.
29. Iida, T., Tohara, H., Wada, S., Nakane, A., Sanpei, R., and Ueda, K. (2013). Aging decreases the strength of suprahyoid muscles involved in swallowing movements. TohokuJExp Med 231, 223-228.
30. Jenal, M., Elkon, R., Loayza-Puch, F., Van Haaften, G., Kuhn, U., Menzies, F.M., Oude Vrielink, J.A., Bos, A.J., Drost, J., Rooijers, K., Rubinsztein, D.C, and Agami, R. (2012). The poly (A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149, 538-553. doi: 10.1016/j.cell.2012.03.022.
31. Kerwitz, Y., Kuhn, U., Lilie, H., Knoth, A., Scheuermann, T., Friedrich, H., Schwarz, E., and Wahle, E. (2003). Stimulation of poly(A) polymerase through a direct interaction w i th the nuclear poly(A) binding protein allosterically regulated by RNA. Emboj 22, 3705-3714. doi: 10.1093/emboj/cdg347.
32. Laberge, A.M., Michaud, J., Richter, A., Lemyre, E., Lambert, M., Brais, B., and Mitchell, G.A. (2005). Population history and its impact on medical genetics in Quebec. Clin Genet 68, 287-301. doi: 10.1111/j.1399-0004.2005.00497.x.
33. Low, P. (2011). The role of ubiquitin-proteasome system in ageing. Gen Comp Endocrinol 172, 39-43. doi: 10.1016/j.ygcen.2011.02.005.
34. Ney, D.M., Weiss, J.M., Kind, A.J., and Robbins, J. (2009). Senescent swallowing: impact, strategies, and interventions. Nutr Clin Pract 24, 395-413. doi: 10.1177/0884533609332005.
35. O'rourke, J.R., and Swanson, M.S. (2009). Mechanisms of RNA-mediated Disease. Journal of Biological Chemistry 284, 7419-7423. doi: 10.1074/jbc. R800025200.
36. Purves-Smith, F.M., Sgarioto, N., and Hepple, R.T. (2014). Fiber typing in aging muscle. Exerc Sport Sci Rev 42, 45-52. doi: 10.1249/jes.0000000000000012.
37. Raz, V., Abraham, T., Van Zwet, E.W., Dirks, R.W., Tanke, H.J., and Van Der Maarel, S.M. (2011a). Reversible aggregation of PABPN1 pre-inclusion structures. Nucleus 2, 208-218. doi: 10.4161/nucl.2.3.15736 1949-1034-2-3-8 [pii].
38. Raz, V., Buijze, H., Raz, Y., Verwey, N., Anvar, S.Y., Aartsma-Rus, A., and Van Der Maarel, S.M. (2014). A Novel Feed-Forward Loop between ARIH2 E3-Ligase and PABPN1 Regulates Aging-Associated Muscle Degeneration. Am J Pathol 30, 00016-00019.
39. Raz, V., Butler-Browne, G., Van Engelen, B., and Brais, B. (2013). 191st ENMC International Workshop: Recent advances in oculopharyngeal muscular dystrophy research: From bench to bedside 8-10 June 2012, Naarden, The Netherlands. Neuromuscular disorders: NMD 23, 516-523.
40. Raz, V., Routledge, S., Venema, A., Buijze, H., Van Der Wal, E., Anvar, S., Straasheijm, K.R., Klooster, R., Antoniou, M., and Van Der Maarel, S.M. (2011b). Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein. Am J Pathol 179, 1988-2000. doi: 10.1016/j.ajpath.2011.06.044.
41. Ross, C.A., and Poirier, M.A. (2005). What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6, 891-898.
42. Ruegg, M.A., and Glass, D.J. (2011). Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol 51, 373-395. doi: 10.1146/annurev-pharmtox-010510-100537.
43. Ruegg, S., Lehky Hagen, M., Hohl, U., Kappos, L., Fuhr, P., Plasilov, M., Muller, H., and Heinimann, K. (2005). Oculopharyngeal muscular dystrophy - an under-diagnosed disorder? Swiss Med Wkly 135, 574-586. doi: 2005/39/smw-11221.
44. Salvi, S.M., Akhtar, S., and Currie, Z. (2006). Ageing changes in the eye. Postgrad Med J 82, 581-587. doi: 10.1136/pgmj.2005.040857.
45. Schindler, J.S., and Kelly, J.H. (2002). Swallowing disorders in the elderly. Laryngoscope 112, 589-602. doi: 10.1097/00005537-200204000-00001.
46. Schneider, J.L., and Cuervo, A.M. (2014). Autophagy and human disease: emerging themes. Curr Opin Genet Dev 26c, 16-23. doi: 10.1016/j.gde.2014.04.003.
47. Sluijs, B., Hoefsloot, L., Padberg, G., Maarel, S., and Engelen, B.M. (2003). Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint. Journalof neurology 250,1307-1312. doi: 10.1007/s00415-003-0201-6.
48. Tavanez, J.P., Calado, P., Braga, J., Lafarga, M., and Carmo-Fonseca, M. (2005). In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. RNA 11, 752-762. doi: rna.7217105 [pii] 10.1261/rna.7217105.
49. Tome, F.M., and Fardeau, M. (1980). Nuclear inclusions in oculopharyngeal dystrophy. Acta neuropathologica 49, 85-87.
50. Trollet, C., Anvar, S.Y., Venema, A., Hargreaves, I.P., Foster, K., Vignaud, A., Ferry, A., Negroni, E., Hourde, C., Baraibar, M.A., T Hoen, P.A., Davies, J.E., Rubinsztein, D.C., Heales, S.J., Mouly, V., Van Der Maarel, S.M., Butler- Browne, G., Raz, V., and Dickson, G. (2010). Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Human molecular genetics 19, 2191-2207. doi: ddq098 [pii] 10.1093/hmg/ddq098.
51. Van Goethem, G., Martin, J.J., and Van Broeckhoven, C. (2003). Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification. Neuromolecular Med 3, 129-146. doi: 10.1385/NMM:3:3:129.
52. Willis, T.A., Hollingsworth, K.G., Coombs, A., Sveen, M.-L., Andersen, S., Stojkovic, T., Eagle, M., Mayhew, A., De Sousa, P.L., Dewar, L., Morrow, J.M., Sinclair, C.D.J., Thornton, J.S., Bushby, K., Lochmüller, H., Hanna, M.G., Hogrel, J.-Y., Carlier, P.G., Vissing, J., and Straub, V. (2013). Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study. PLoS ONE 8, e70993. doi: 10.1371/journal.pone.0070993.
53. Witting, N., Mensah, A., Kober, L., Bundgaard, H., Petri, H., Duno, M., Milea, D., and Vissing, J. (2014). Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy. Acta Neurol Scand 130,125-130. doi: 10.1111/ane.12244.
54. Yokoyama, M., Mitomi, N., Tetsuka, K., Tayama, N., and Niimi, S. (2000). Role of laryngeal movement and effect of aging on swallowing pressure in the pharynx and upper esophageal sphincter. Laryngoscope 110, 434-439. doi: 10.1097/00005537-200003000-00021.
55. Yu-Wai-Man, P., Lai-Cheong, J., Borthwick, G.M., He, L., Taylor, G.A., Greaves, L.C., Taylor, R.W., Griffiths, P.G., and Turnbull, D.M. (2010). Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles. Invest Ophthalmol VisSci 51, 3347-3353. doi: 10.1167/iovs.09-4660.